Clinical Trial: Open and Comparative Study to Measure Tolerability and Efficacy of Taro Elixir

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Multicenter Clinical Study,Phase III, Prospective, Randomized, Open and Comparative to Measure Tolerability and Efficacy of Taro Elixir on the Evolution Treatment of Acne Vulgaris II and III Degree or

Brief Summary: To measure the efficacy of Taro Elixir compare with Oxytetracycline in the treatment of boils or acne.

Detailed Summary:
Sponsor: Laboratorios Goulart S.A.

Current Primary Outcome: Measure the efficacy in the treatment of boils or acne vulgaris II and III degree with taro elixir compared with Oxytetracycline. [ Time Frame: 90 days ]

Original Primary Outcome: Measure the efficacy in the treatment of boils or acne vulgaris II and III degree with yam elixir compared with Oxytetracycline. [ Time Frame: 90 days ]

Current Secondary Outcome: Measure the tolerability in the treatment evolution of boils or acne vulgaris II and III with taro elixir compare with Oxytetracycline. [ Time Frame: 90 days ]

Original Secondary Outcome: Measure the tolerability in the treatment evolution of boils or acne vulgaris II and III with yam elixir compare with Oxytetracycline. [ Time Frame: 90 days ]

Information By: Laboratorios Goulart S.A.

Dates:
Date Received: December 14, 2009
Date Started: May 2010
Date Completion: October 2010
Last Updated: March 18, 2010
Last Verified: December 2009